Phase <scp>II</scp> Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (<scp>ACC</scp>) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors
2025 · Cancer Medicine · 4 citations
https://doi.org/10.1002/cam4.70724